greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2015

Sanofi (SNY) annual results, year to 31 December 2015: revenue EUR 34,060 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2015 it reported revenue from the sale of goods of EUR 34,060 million ($37.8 billion at the year's average rate). Its profit attributable to shareholders was EUR 4,287 million, and diluted earnings per share EUR 3.25.

Revenue
EUR 34,060 million
FY2015FY2015
Operating margin
16.5%
FY2015FY2015
Net income
EUR 4,287 million
FY2015FY2015
Diluted EPS
EUR 3.25
FY2015FY2015

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2015
Revenue from the sale of goods34,060
Cost of sales10,919
Gross profit23,942
Research and development5,082
Selling, general and administrative9,382
Operating profit5,624
Finance costs559
Income tax709
Profit for the year4,388
Profit attributable to shareholders4,287
Filing20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2015
Diluted EPS3.25
Basic EPS3.28
Filing20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2015
Cash from operations8,290
Cash from investing-3,011
Cash from financing-3,578
Buybacks1,784
Dividends paid3,694
Filing20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2015
Funded by
Equity attributable to shareholders58,049
Non-controlling interests161
Borrowings, as filed16,398
Other liabilities27,713
Total equity and liabilities102,321
Owned
Property, plant and equipment9,943
Goodwill39,557
Other intangible assets12,026
Cash and cash equivalents9,148
Inventories6,516
Other assets25,131
Total assets102,321
Filing20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2015
Return on year-end equity7.4%
Filing20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2015, filed 16 March 2018: the filing. The figures are in euros as filed.